Megestrol acetate for treatment of advanced carcinoma of the prostate
โ Scribed by Douglas E. Johnson; Kelly E. Kaesler; Alberto G. Ayala
- Publisher
- John Wiley and Sons
- Year
- 1975
- Tongue
- English
- Weight
- 366 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Megestrol acetate (MA) is a synthetic progestin with reported activity in both hormone-sensitive and hormone-refractory prostate carcinoma (HRPC). Based on limited data suggesting a possible dose-response effect, a trial was initiated to compare standard versus moderately high dose M
## BACKGROUND. Although many physicians measure serum prostate specific antigen (PSA) during the follow-up of patients with hormone refractory prostate carcinoma (HRPC), little has been done to formalize the determination of how these serial values of PSA impact on prognosis. To understand HRPC fu
## Background: The incidence of hepatoblastoma in children of very low birth weight (< 1500 g) is increasing in japan. the authors reviewed surgical and pathologic aspects of the tumor to clarify the characteristics of the patients. ## Methods: Fifteen patients (9 boys and 6 girls) who were diagn